Literature DB >> 22153789

Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Bart C J M Fauser1, Basil C Tarlatzis, Robert W Rebar, Richard S Legro, Adam H Balen, Roger Lobo, Enrico Carmina, Jeffrey Chang, Bulent O Yildiz, Joop S E Laven, Jacky Boivin, Felice Petraglia, C N Wijeyeratne, Robert J Norman, Andrea Dunaif, Stephen Franks, Robert A Wild, Daniel Dumesic, Kurt Barnhart.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in females, with a high prevalence. The etiology of this heterogeneous condition remains obscure, and its phenotype expression varies. Two widely cited previous ESHRE/ASRM sponsored PCOS consensus workshops focused on diagnosis (published in 2004) and infertility management (published in 2008), respectively. The present third PCOS consensus report summarizes current knowledge and identifies knowledge gaps regarding various women's health aspects of PCOS. Relevant topics addressed-all dealt with in a systematic fashion-include adolescence, hirsutism and acne, contraception, menstrual cycle abnormalities, quality of life, ethnicity, pregnancy complications, long-term metabolic and cardiovascular health, and finally cancer risk. Additional, comprehensive background information is provided separately in an extended online publication.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22153789     DOI: 10.1016/j.fertnstert.2011.09.024

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  356 in total

1.  Reproductive endocrinology: Infertility treatment in PCOS--is metformin in from the cold?

Authors:  Evanthia Diamanti-Kandarakis
Journal:  Nat Rev Endocrinol       Date:  2012-05-01       Impact factor: 43.330

Review 2.  Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

Authors:  Selma F Witchel; Sergio E Recabarren; Frank González; Evanthia Diamanti-Kandarakis; Kai I Cheang; Antoni J Duleba; Richard S Legro; Roy Homburg; Renato Pasquali; Rogerio A Lobo; Christos C Zouboulis; Fahrettin Kelestimur; Franca Fruzzetti; Walter Futterweit; Robert J Norman; David H Abbott
Journal:  Endocrine       Date:  2012-06-04       Impact factor: 3.633

3.  Lipid-induced mononuclear cell cytokine secretion in the development of metabolic aberration and androgen excess in polycystic ovary syndrome.

Authors:  F González; R V Considine; O A Abdelhadi; A J Acton
Journal:  Hum Reprod       Date:  2020-05-01       Impact factor: 6.918

Review 4.  Sex, Microbes, and Polycystic Ovary Syndrome.

Authors:  Varykina G Thackray
Journal:  Trends Endocrinol Metab       Date:  2018-11-29       Impact factor: 12.015

Review 5.  Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.

Authors:  Rodolfo C Cardoso; Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Neuroendocrinology       Date:  2015-04-01       Impact factor: 4.914

Review 6.  Does a male polycystic ovarian syndrome equivalent exist?

Authors:  R Cannarella; R A Condorelli; L M Mongioì; S La Vignera; A E Calogero
Journal:  J Endocrinol Invest       Date:  2017-07-15       Impact factor: 4.256

7.  Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria.

Authors:  Miro Šimun Alebić; Tomislav Bulum; Nataša Stojanović; Lea Duvnjak
Journal:  Endocrine       Date:  2014-02-13       Impact factor: 3.633

8.  Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case-control studies.

Authors:  D Liao; H Yu; L Han; C Zhong; X Ran; D Wang; L Mo
Journal:  J Endocrinol Invest       Date:  2018-03-15       Impact factor: 4.256

Review 9.  Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation.

Authors:  Maureen M B Schulte; Jui-he Tsai; Kelle H Moley
Journal:  Reprod Sci       Date:  2014-12-07       Impact factor: 3.060

10.  The efficacy of metformin in pregnant women with polycystic ovary syndrome: a meta-analysis of clinical trials.

Authors:  J Zheng; P F Shan; W Gu
Journal:  J Endocrinol Invest       Date:  2013-04-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.